Novavax
NVAX
$4.18
Share price
2.08%
Change (1 day)
-45.57%
Change (1 year)
Categories
Novavax (NVAX) - Total assets
Total assets on the balance sheet as of December 2023 : $1.79 B
According to Novavax's latest financial reports the company's total assets are $1.79 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Novavax - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.79 B | -20.42% |
| 2022-12-31 | $2.25 B | -12.34% |
| 2021-12-31 | $2.57 B | 62.83% |
| 2020-12-31 | $1.58 B | 814.96% |
| 2019-12-31 | $0.17 B | -16.84% |
| 2018-12-31 | $0.20 B | -31.25% |
| 2017-12-31 | $0.30 B | -23.28% |
| 2016-12-31 | $0.39 B | 2.14% |
| 2015-12-31 | $0.38 B | 39.87% |
| 2014-12-31 | $0.27 B | 17.39% |
| 2013-12-31 | $0.23 B | 129.74% |
| 2012-12-31 | $0.10 B | 53.73% |
| 2011-12-31 | $66.57 M | -11.05% |
| 2010-12-31 | $74.84 M | -12.57% |
| 2009-12-31 | $85.6 M | 11.72% |
| 2008-12-31 | $76.62 M | -16.07% |
| 2007-12-31 | $91.29 M | -25.1% |
| 2006-12-31 | $0.12 B | 44.43% |
| 2005-12-31 | $84.38 M | 8.19% |
| 2004-12-31 | $77.99 M | -7.33% |
| 2003-12-31 | $84.15 M | 46.35% |
| 2002-12-31 | $57.5 M | -14.32% |
| 2001-12-31 | $67.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $94.33 B | 5,148.10% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 12,500.96% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 5,590.88% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $75.11 B | 4,078.79% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $3.26 B | 81.62% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.46 B | -74.10% | 🇺🇸 USA |
 Agenus
AGEN | $0.31 B | -82.54% | 🇺🇸 USA |
 NanoViricides NNVC | $13.4 M | -99.25% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.51 B | -71.24% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.82 B | 1.43% | 🇺🇸 USA |